Problem adaptation therapy for individuals with mild to moderate dementia and depression: the PATHFINDER trial

OCLOR0 个研究点目标入组 336 人开始时间: 2018年5月31日最近更新: 2022年8月5日

试验速览

暂无简介。

•1. Diagnosis of probable AD or mixed AD and vascular dementia using NIA-AA criteria
•2. Mild to moderate dementia severity, defined by an SMMSE score >10
•3. Clinically significant depression, defined by score of 8+ on the Cornell Scale for Depression in Dementia
•4. Aged >50 years
•5. Sufficiently fluent in English to engage with the PATH intervention
•6. Identified family carer who spends >1 hour per day on at least 3 days per week with participant and agrees to act as co-therapist for intervention

•1. Diagnosis of rarer dementias, including dementia with Lewy bodies, Parkinson’s disease dementia and frontotemporal dementia
•2. Initiation of prescription or change in dose of antidepressant or other psychotropic medication in previous 4 weeks or plan to change treatment during the next 12 weeks
•3. Those currently engaged in formal psychological therapy
•4. Those requiring treatment for a severe psychiatric disorder such as schizophrenia or bipolar disorder
•5. Are severely depressed and expressing suicidal ideation with active plans/suicidal behaviours and intent, as other forms of treatment and support would be indicated

发起方

OCLOR